{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:51:26Z","timestamp":1785858686873,"version":"3.56.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1097\/01.mbc.0000187252.09759.ba","type":"journal-article","created":{"date-parts":[[2005,11,2]],"date-time":"2005-11-02T04:01:10Z","timestamp":1130904070000},"page":"557-562","source":"Crossref","is-referenced-by-count":28,"title":["Platelet hyper-function in acute coronary syndromes"],"prefix":"10.1097","volume":"16","author":[{"given":"Paul","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique SC","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge D","family":"Erusalimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J","family":"Machin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","article-title":"Aspirin, heparin, or both to treat acute unstable angina","volume":"319","author":"Theroux","year":"1988","journal-title":"N Engl J Med"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0735-1097(98)00635-4","article-title":"Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction","volume":"33","author":"Ault","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/euhj.1997.0747","article-title":"Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain","volume":"19","author":"Pizzulli","year":"1998","journal-title":"Eur Heart J"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/0140-6736(91)92719-I","article-title":"Influence of platelet size on outcome after myocardial infarction","volume":"338","author":"Martin","year":"1991","journal-title":"Lancet"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/bmj.289.6458.1576","article-title":"High mean platelet volume after myocardial infarction: is it due to consumption of small platelets?","volume":"289","author":"Sewell","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0002-8703(98)70212-1","article-title":"Heterogeneity of platelet aggregation and major surface receptor expression in patients with acute myocardial infarction","volume":"136","author":"Serebruany","year":"1998","journal-title":"Am Heart J"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0735-1097(97)00510-X","article-title":"Increased platelet reactivity and circulating monocyte\u2013platelet aggregates in patients with stable coronary artery disease","volume":"31","author":"Furman","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00019501-199404000-00010","article-title":"The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group","volume":"5","author":"Becker","year":"1994","journal-title":"Coron Artery Dis"},{"key":"R9-4-20210203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF01063163","article-title":"Dynamic nature of thrombin generation, fibrin formation, and platelet activation in unstable angina and non-Q-wave myocardial infarction","volume":"2","author":"Becker","year":"1995","journal-title":"J Thromb Thrombolysis"},{"issue":"Suppl 1","key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2362.1994.tb02426.x","article-title":"Markers of platelet activation in coronary heart disease patients","volume":"24","author":"Nurden","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"R11-4-20210203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cvr\/24.1.19","article-title":"Differences in bleeding time, aspirin sensitivity and adrenaline between acute myocardial infarction and unstable angina","volume":"24","author":"Kristensen","year":"1990","journal-title":"Cardiovasc Res"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/09537109909169175","article-title":"Can the platelet function analyser (PFA-100) test substitute for the template bleeding time in routine clinical practice?","volume":"10","author":"Francis","year":"1999","journal-title":"Platelets"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1182\/blood.V91.4.1325","article-title":"Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases","volume":"91","author":"Fressinaud","year":"1998","journal-title":"Blood"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-8652(199911)62:3<165::AID-AJH6>3.0.CO;2-C","article-title":"Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders","volume":"62","author":"Favaloro","year":"1999","journal-title":"Am J Hematol"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001721-199901000-00004","article-title":"Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis","volume":"10","author":"Harrison","year":"1999","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0049-3848(99)00152-8","article-title":"Comparison of PFA-100 closure time and template bleeding time of patients with inherited disorders causing defective platelet function","volume":"96","author":"Kerenyi","year":"1999","journal-title":"Thromb Res"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1055\/s-2007-996051","article-title":"Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting","volume":"24","author":"Rand","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0037-1613805","article-title":"Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100","volume":"83","author":"Homoncik","year":"2000","journal-title":"Thromb Haemost"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2125.1997.00639.x","article-title":"A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers","volume":"44","author":"Marshall","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1161\/01.CIR.80.2.410","article-title":"Unstable angina. A classification","volume":"80","author":"Braunwald","year":"1989","journal-title":"Circulation"},{"key":"R21-4-20210203","first-page":"1210","article-title":"Acute myocardial infarction","author":"Antman","year":"1997"},{"key":"R22-4-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1055\/s-0037-1613290","article-title":"Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance","volume":"88","author":"McKee","year":"2002","journal-title":"Thromb Haemost"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1046\/j.1538-7836.2003.00284.x","article-title":"Aspirin resistance: definition, mechanisms and clinical read-outs","volume":"1","author":"Patrono","year":"2003","journal-title":"J Thromb Haemost"},{"key":"R25-4-20210203","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0735-1097(02)03013-9","article-title":"Aspirin resistance: a new independent predictor of vascular events?","volume":"41","author":"Eikelboom","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/09537100400020567","article-title":"Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA","volume":"16","author":"McCabe","year":"2005","journal-title":"Platelets"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/69537100412351272550","article-title":"The PFA-100 detects sub-optimal antiplatelet responses in patients on aspirin","volume":"15","author":"Sambola","year":"2004","journal-title":"Platelets"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1067\/mlc.2001.117406","article-title":"Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction","volume":"138","author":"Jilma","year":"2001","journal-title":"J Lab Clin Med"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1365-2141.2003.04727.x","article-title":"In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor","volume":"124","author":"Chakroun","year":"2004","journal-title":"Br J Haematol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0049-3848(02)00210-4","article-title":"Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate","volume":"107","author":"Macchi","year":"2002","journal-title":"Thromb Res"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00415-003-0954-y","article-title":"Aspirin non-responder status in patients with recurrent cerebral ischemic attacks","volume":"250","author":"Grundmann","year":"2003","journal-title":"J Neurol"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0049-3848(02)00405-X","article-title":"Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease","volume":"108","author":"Andersen","year":"2002","journal-title":"Thromb Res"},{"key":"R34-4-20210203","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0735-1097(03)00999-9","article-title":"Determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"42","author":"Steinhubl","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","article-title":"Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis; Working Group on Aspirin Resistance. Aspirin resistance: position paper of the Working Group on Aspirin Resistance","volume":"3","author":"Michelson","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.1182\/blood-2002-11-3566","article-title":"Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb\/IIIa inhibitors and aspirin","volume":"102","author":"Reiter","year":"2003","journal-title":"Blood"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/01.CIR.0000141575.92958.9C","article-title":"Platelet function predicts myocardial damage in patients with acute myocardial infarction","volume":"110","author":"Frossard","year":"2004","journal-title":"Circulation"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01241398-200511000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:56:13Z","timestamp":1785855373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200511000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000187252.09759.ba","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}